“CD8+ As a Predictive Factor for Response to Anthracycline-Based Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer at Dr. Soetomo General Hospital, Surabaya, January 2024-August 2025”. 2025. Vascular and Endovascular Review 8 (13s): 155-61. https://doi.org/10.64149/.